Davenport & CO LLC Zoetis Inc. Transaction History

Davenport & CO LLC

$16.7 Billion
Q4 2024

A detailed history of Davenport & CO LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Davenport & CO LLC holds 62,078 shares of ZTS stock, worth $10 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

62,078

Previous 55,806 11.24%

Holding current value

$10 Million

Previous $10.9 Million 7.24%

% of portfolio

0.06%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	BUY	$162.24 - $194.42 $1.02 Million - $1.22 Million	6,272 Added 11.24%	62,078 $10.1 Million
Q3 2024 Oct 24, 2024	SELL	$172.58 - $196.48 $109,588 - $124,764	-635 Reduced 1.13%	55,806 $10.9 Million
Q2 2024 Aug 06, 2024	BUY	$145.54 - $178.83 $527,582 - $648,258	3,625 Added 6.86%	56,441 $9.78 Million
Q1 2024 May 03, 2024	BUY	$165.67 - $199.94 $774,838 - $935,119	4,677 Added 9.72%	52,816 $8.94 Million
Q4 2023 Jan 23, 2024	BUY	$151.44 - $200.09 $122,969 - $162,473	812 Added 1.72%	48,139 $9.5 Million
Q3 2023 Oct 17, 2023	BUY	$167.14 - $192.77 $93,264 - $107,565	558 Added 1.19%	47,327 $8.23 Million
Q2 2023 Jul 20, 2023	BUY	$160.94 - $186.23 $207,773 - $240,422	1,291 Added 2.84%	46,769 $8.05 Million
Q1 2023 Apr 27, 2023	BUY	$145.48 - $175.02 $1.36 Million - $1.64 Million	9,346 Added 25.87%	45,478 $7.57 Million
Q4 2022 Jan 20, 2023	BUY	$131.14 - $157.47 $512,888 - $615,865	3,911 Added 12.14%	36,132 $0
Q3 2022 Oct 11, 2022	BUY	$148.29 - $182.55 $356,785 - $439,215	2,406 Added 8.07%	32,221 $4.78 Million
Q2 2022 Jul 18, 2022	BUY	$155.97 - $200.09 $618,109 - $792,956	3,963 Added 15.33%	29,815 $5.13 Million
Q1 2022 May 02, 2022	BUY	$181.39 - $234.03 $142,391 - $183,713	785 Added 3.13%	25,852 $4.88 Million
Q4 2021 Feb 10, 2022	SELL	$193.69 - $247.03 $55,007 - $70,156	-284 Reduced 1.12%	25,067 $6.12 Million
Q3 2021 Oct 14, 2021	BUY	$189.29 - $209.69 $258,002 - $285,807	1,363 Added 5.68%	25,351 $4.92 Million
Q2 2021 Jul 28, 2021	BUY	$155.9 - $187.99 $556,095 - $670,560	3,567 Added 17.47%	23,988 $4.47 Million
Q1 2021 Apr 28, 2021	SELL	$144.0 - $169.39 $174,960 - $205,808	-1,215 Reduced 5.62%	20,421 $3.22 Million
Q4 2020 Jan 13, 2021	SELL	$157.07 - $174.35 $29.6 Million - $32.8 Million	-188,236 Reduced 89.69%	21,636 $3.58 Million
Q3 2020 Oct 15, 2020	SELL	$137.1 - $165.37 $229,642 - $276,994	-1,675 Reduced 0.79%	209,872 $34.7 Million
Q2 2020 Jul 28, 2020	BUY	$111.92 - $142.53 $53,273 - $67,844	476 Added 0.23%	211,547 $29 Million
Q1 2020 May 05, 2020	SELL	$92.66 - $144.94 $6.05 Million - $9.46 Million	-65,273 Reduced 23.62%	211,071 $24.8 Million
Q4 2019 Jan 22, 2020	SELL	$116.25 - $133.25 $1.9 Million - $2.18 Million	-16,373 Reduced 5.59%	276,344 $36.6 Million
Q3 2019 Oct 16, 2019	SELL	$112.57 - $128.43 $2.74 Million - $3.13 Million	-24,382 Reduced 7.69%	292,717 $34.7 Million
Q2 2019 Jul 10, 2019	SELL	$97.98 - $114.28 $421,118 - $491,175	-4,298 Reduced 1.34%	317,099 $36 Million
Q1 2019 Apr 17, 2019	SELL	$81.56 - $100.67 $173,722 - $214,427	-2,130 Reduced 0.66%	321,397 $32.4 Million
Q4 2018 Jan 28, 2019	SELL	$79.28 - $95.27 $3.71 Million - $4.45 Million	-46,760 Reduced 12.63%	323,527 $27.7 Million
Q3 2018 Oct 11, 2018	SELL	$83.5 - $93.23 $657,562 - $734,186	-7,875 Reduced 2.08%	370,287 $33.9 Million
Q2 2018 Jul 09, 2018	SELL	$79.9 - $89.2 $4.27 Million - $4.76 Million	-53,404 Reduced 12.37%	378,162 $32.2 Million
Q1 2018 Apr 04, 2018	BUY	$71.51 - $84.69 $88,457 - $104,761	1,237 Added 0.29%	431,566 $36 Billion
Q4 2017 Jan 17, 2018	BUY	$63.24 - $72.8 $727,829 - $837,855	11,509 Added 2.75%	430,329 $31 Billion
Q3 2017 Oct 12, 2017	BUY	$59.73 - $65.4 $25 Million - $27.4 Million	418,820	418,820 $26.7 Billion

Others Institutions Holding ZTS

# of Institutions

2,060

Shares Held

420M

Call Options Held

1.22M

Put Options Held

1.61M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $75.5B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account